Our study provides valuable insights into ligand interactions with ATF4‐G4 and paves the way for targeting the ATF4‐G4 structure to impede tumor growth, which is a critical aspect in the development of drugs that interact with ATF4‐G4. The gene discussed is ATF4; the disease is neoplasm.